Quantum-Si incorporated (QSI)
Market Cap | 357.82M |
Revenue (ttm) | 3.44M |
Net Income (ttm) | -100.72M |
Shares Out | 183.50M |
EPS (ttm) | -0.66 |
PE Ratio | n/a |
Forward PE | n/a |
Dividend | n/a |
Ex-Dividend Date | n/a |
Volume | 12,397,294 |
Open | 2.055 |
Previous Close | 2.050 |
Day's Range | 1.870 - 2.060 |
52-Week Range | 0.612 - 5.770 |
Beta | 2.90 |
Analysts | Strong Buy |
Price Target | 2.38 (+22.05%) |
Earnings Date | Aug 6, 2025 |
About QSI
Quantum-Si incorporated, a life sciences company, engages in the development of single-molecule detection platform to enable Next Generation Protein Sequencing (NGPS). The company offers Platinum NGPS instrument that provides single molecule amino acid level resolution with a streamlined workflow, including automated data analysis that accessible to researchers in all laboratory types; Platinum Pro NGPS instrument, a single molecule amino acid resolution, which provides an enhanced user interface, cloud or on instrument data analysis and an ava... [Read more]
Financial Performance
In 2024, Quantum-Si incorporated's revenue was $3.06 million, an increase of 182.62% compared to the previous year's $1.08 million. Losses were -$101.01 million, 5.26% more than in 2023.
Financial StatementsAnalyst Forecast
According to 3 analysts, the average rating for QSI stock is "Strong Buy." The 12-month stock price forecast is $2.38, which is an increase of 22.05% from the latest price.
News

Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Platinum® Pro Instrument Placed at the Broad Institute to Support Regional Research Initiatives.

Quantum-Si to Join Leading Experts from DNAnexus, Olink, and Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration and Standardization
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Join Leading Experts from DNAnexus, Olink, & Northwestern in Upcoming GenomeWeb Webinar on Proteomics Data Integration & Standardization.

Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Customer to Showcase Protein Barcoding for Nucleic Acid–LNP Therapeutic Development at Festival of Genomics Boston.

Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4).

Quantum-Si's Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay
BRANFORD, Conn.--(BUSINESS WIRE)--Single-Molecule Tech Enables Precise, Multiplexed Measurement of Nanobody Binding in a Single Assay.

Quantum-Si: Sell On Weak Prospects And Risk Of Further Dilution
After mistakenly having been picked up as a quantum computing play in late 2024, shares of life sciences company, Quantum-Si, have given back most of their gains in recent months. While the company us...

Quantum-Si incorporated (QSI) Q1 2025 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q1 2025 Earnings Conference Call May 15, 2025 4:30 PM ET Company Participants Jeff Hawkins - President and CEO Jeff Keyes - CFO Conference Call Participants Kyle ...

Quantum-Si Reports First Quarter 2025 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports First Quarter 2025 Financial Results; Launches & Delivers First Platinum® Pro Units; Announces New Library Prep Development Program.

Dr. Gloria Sheynkman from the University of Virginia to Present Pioneering Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Upcoming Nature Webinar on May 15
BRANFORD, Conn.--(BUSINESS WIRE)--Dr. Gloria Sheynkman, University of Virginia, Presents Research utilizing Quantum-Si's Next-Gen Protein Sequencing™ Platform in Nature Webinar on 5/15.

Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report First Quarter 2025 Financial Results on May 15, 2025.

Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Begins Shipping Platinum® Pro, Advancing Accessibility in Next-Gen Protein Sequencing™.

Quantum-Si to Participate in DNAnexus Webinar on Large Scale Proteomics in Multi-Omics Research
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to participate in DNAnexus webinar on large scale proteomics in multi-omics research.

Quantum-Si: A Rose, By Any Other Name, Wouldn't Smell As Sweet
Quantum-Si aims to revolutionize protein sequencing but faces significant technological and competitive challenges. Commercial reception to Quantum-Si's solutions has been lukewarm so far, suggesting ...

Quantum-Si incorporated (QSI) Q4 2024 Earnings Call Transcript
Quantum-Si incorporated (NASDAQ:QSI) Q4 2024 Earnings Conference Call March 3, 2025 4:30 PM ET Company Participants Katherine Atkins - SVP, Commercial Markets Jeff Hawkins - President and CEO Jeff Ke...

Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Reports Fourth Quarter and Full Year 2024 Financial Results.

Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's Customers and Researchers to Showcase Next-Generation Protein Sequencing™ at AGBT 2025.

Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and Researchers to Showcase Next-Generation Protein Sequencing™ at US HUPO 2025.

Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025.

Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Establishes Scientific Advisory Board to Shape Next-Generation Proteomic Technologies.

Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si and IDEX Health & Science to Partner on Optics Module for Proteus™ Instrument.

Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Showcases Advances in Multiomics at the Festival of Genomics UK.

Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Launches Platinum® Pro: The End-to-End Solution for Deeper Insights in Proteomics.

Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si's New Preprint Showcases Protein Barcoding as a Powerful Tool for Transforming Proteomics.

Quantum-Si's 327% Rally In Six Months: Is Nvidia The Catalyst For More Gains?
Quantum-Si Inc. QSI is stealing the biotech spotlight with a jaw-dropping 327% surge over the past six months. The proteomics pioneer's stock now sits at $4.10, boasting a strong bullish trend and cat...

Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock
BRANFORD, Conn.--(BUSINESS WIRE)--Quantum-Si Incorporated Announces Pricing of $50 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules.